Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > EBITDA / Interest Expenses

Bristol-Myers Squibb Company EBITDA / Interest Expenses Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Bristol-Myers Squibb Company EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $14m a 37.84% increase of 5m year over year
  • Bristol-Myers Squibb Company EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $13m a -6.92% decrease of -1m year over year
  • Bristol-Myers Squibb Company Annual EBITDA / Interest Expenses for 2019 was $14m a -182.27% decrease of -25m from 2018
  • Bristol-Myers Squibb Company Annual EBITDA / Interest Expenses for 2018 was $38m a 39.18% increase of 15m from 2017
  • Bristol-Myers Squibb Company Annual EBITDA / Interest Expenses for 2017 was $23m a -46.84% decrease of -11m from 2016
Other Ratios Metrics:
  • Bristol-Myers Squibb Company Total Debt / Capital for the quarter ending December 12, 2018 was $35m a -7.68% decrease of -3m year over year
  • Bristol-Myers Squibb Company Other Liabilities for the quarter ending September 09, 2018 was $4,603m a -12.23% decrease of -563m year over year
  • Bristol-Myers Squibb Company Total Debt / Equity for the quarter ending December 12, 2018 was $53m a -12.27% decrease of -7m year over year
View Chart On Koyfin

Quarterly BMY EBITDA / Interest Expenses Data

09/2020$14m
06/2020$14m
03/2020$14m
12/2019$9m
09/2019$10m
06/2019$20m
03/2019$52m
12/2018$23m
09/2018$51m
06/2018$49m

Annual BMY EBITDA / Interest Expenses Data

2019$14m
2018$38m
2017$23m
2016$34m
2015$24m
2014$20m
2013$21m
2012$29m
2011$54m
2010$48m